Management of the catheter in documented catheter-related coagulase-negative staphylococcal bacteremia: Remove or retain?

Clinical Infectious Diseases

Volumn 49, Issue 8, 2009, Pages 1187-1194

  Raad, Issam ^a,c   Kassar, Rawan ^a   Ghannam, Dany ^b   Chaftari, Anne Marie ^a   Hachem, Ray ^a   Jiang, Ying ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Kadlec Medical Center   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; BACTEREMIA; BLOOD CULTURE; CATHETER; CHILD; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CHILD; CHILD, PRESCHOOL; COAGULASE; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70349909843     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/605694     Document Type: Article

References (32)

1. 1. Herwaldt LA, Geiss M, Kao C, Pfaller MA. The positive predictive value of isolating coagulase-negative staphylococci from blood cultures. Clin Infect Dis 1996;22:14-20. (Pubitemid 2618189)
2. Tokars JI. Predictive value of blood cultures positive for coagulasenegative staphylococci: implications for patient care and health care quality assurance. Clin Infect Dis 2004;39:333-341
3. Lee CC, Lin WJ, Shih HI, et al. Clinical significance of potential contaminants in blood cultures among patients in a medical center. J Microbiol Immunol Infect 2007;40:438-444
4. 4. Edmond MB, Wallace SE, McClish DK, Pfeiler MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999; 29:239-244 (Pubitemid 29380177)
5. 5. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004;39:309-317 (Pubitemid 39050477)
6. O'Gara JP, Humphreys H. Staphylococcus epidermidis biofilms: importance and implications. J Med Microbiol 2001;50:582-587
7. Mack D, Davies AP, Harris LG, Rohde H, Horstkotte MA, Knobloch JK. Microbial interactions in Staphylococcus epidermidis biofilms. Anal Bioanal Chem 2007; 387:399-408.
8. Qin Z, Yang X, Yang L, et al. Formation and properties of in vitro biofilms of ica-negative Staphylococcus epidermidis clinical isolates. J Med Microbiol 2007;56:83-93.
9. 9. Souli M, Giamarellou H. Effects of slime produced by clinical isolates of coagulase-negative staphylococci on activities of various antimicrobial agents. Antimicrob Agents Chemother 1998;42:939-941 (Pubitemid 28216385)
10. Villain-Guillot P, Gualtieri M, Bastide L, Leonetti JP. In vitro activities of different inhibitors of bacterial transcription against Staphylococcus epidermidis biofilm. Antimicrob Agents Chemother 2007;51:3117-3121
11. Curtin J, Cormican M, Fleming G, Keelehan J, Colleran E. Linezolid compared with epcrezolid, vancomycin, and gcntamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob Agents Chemother 2003;47:3145-3148
12. Evans RC, Holmes CJ. Effect of vancomycin hydrochloride on Staphylococcus epidermidis biofilm associated with silicone elastomer. Antimicrob Agents Chemother 1987;31:889-894
13. Farber BF, Kaplan MH, Clogston AG. Staphylococcus epidermidis extracted slime inhibits the antimicrobial action of glycopeptide antibiotics. J Infect Dis 1990; 161:37-40.
14. Petersen PJ, Bradford PA, Weiss WJ, Murphy TM, Sum PE, Projan SJ. In vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant gram-positive pathogens. Antimicrob Agents Chemother 2002;46:2595-2601
15. Wiederhold NP, Coyle EA, Raad II, Prince RA, Lewis RE. Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia. J Antimicrob Chemother 2005; 55:792-795
16. Raad I, Hanna H, Jiang Y, et al. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother 2007;51:1656-1660
17. 17. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001; 32: 1249-1272 (Pubitemid 32405897)
18. Rao JS, O'Meara A, Harvey T, Breatnach F. A new approach to the management of Broviac catheter infection. J Hosp Infect 1992; 22:109-116
19. 19. Capdevila JA, Segarra A, Planes AM, et al. Successful treatment of haemodialysis catheter-related sepsis without catheter removal. Nephrol Dial Transplant 1993;8:231-234 (Pubitemid 23122974)
20. Lamy B, Roy P, Carret G, Flandrois JP, Delignette-Muller ML. What is the relevance of obtaining multiple blood samples for culture? a comprehensive model to optimize the strategy for diagnosing bacteremia. Clin Infect Dis 2002;35:842-850
21. Peacock SJ, Bowler IC, Crook DW. Positive predictive value of blood cultures growing coagulase-negative staphylococci. Lancet 1995; 346: 191-2.
22. Ruhe J, Menon A, Mushatt D, Dejace P, Hasbun R. Non-epidermidis coagulase-negative staphylococcal bacteremia: clinical predictors of true bacteremia. Eur J Clin Microbiol Infect Dis 2004; 23:495-498
23. 23. Chatzinikolaou I, Hanna H, Darouiche R, Samonis G, Tarrand J, Raad I. Prospective study of the value of quantitative culture of organisms from blood collected through central venous catheters in differentiating between contamination and bloodstream infection. J Clin Microbiol 2006;44:1834-1835 (Pubitemid 43726277)
24. Rivera J, Kassar R, Kassis C, et al. When does molecular genotyping and phenotyping of coagulase negative staphylococci (CNS) isolated from blood culture (BC) correlate with clinical/CDC criteria for true bacteremia [abstract D-304]? In: Program and abstracts of the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy/Infectious Diseases Society of America Conference. Washington, DC: American Society for Microbiology, 2008:223.
25. 25. Scrucca L, Santucci A, Aversa F. Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplantation 2007;40:381-387 (Pubitemid 47202424)
26. 26. Martinez JA, Desjardin JA, Aronoff M, Supran S, Nasraway SA, Snydman DR. Clinical utility of blood cultures drawn from central venous or arterial catheters in critically ill surgical patients. Crit Care Med 2002;30:7-13. (Pubitemid 34112170)
27. 27. Desjardin JA, Falagas ME, Ruthazer R, et al. Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer. Ann Intern Med 1999; 131:641-647 (Pubitemid 29517948)
28. 28. Rubin LG, Shih S, Shende A, Karayalcin G, Lanzkowsky P. Cure of implantable venous port-associated bloodstream infections in pediatric hematology-oncology patients without catheter removal. Clin Infect Dis 1999;29:102-105 (Pubitemid 29336810)
29. Rosen AB, Fowler VG Jr, Corey GR, et al. Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia. Ann Intern Med 1999;130:810-820
30. 30. Coyle VM, McMullan R, Morris TC, Rooney PJ, Hedderwick S. Catheter-related bloodstream infection in adult haematology patients: catheter removal practice and outcome. J Hosp Infect 2004;57:325-331 (Pubitemid 39023362)
31. Raad I, Davis S, Khan A, Tarrand J, Elting L, Bodey GP. Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococcal bacteremia. Infect Control Hosp Epidemiol 1992; 13:215-221
32. 32. Flynn PM, Willis B, Gaur AH, Shenep JL. Catheter design influences recurrence of catheter-related bloodstream infection in children with cancer. J Clin Oncol 2003;21:3520-3525 (Pubitemid 46594086)